Luma Health vs Pfizer

Side-by-side comparison of AI visibility scores, market position, and capabilities

Pfizer leads in AI visibility (93 vs 39)
Luma Health logo

Luma Health

EmergingHealthcare

Patient Engagement

Patient engagement platform with automated SMS reminders, self-scheduling, and EHR integration for health systems; $130M+ a16z-backed competing with Phreesia for healthcare communication automation.

AI VisibilityBeta
Overall Score
D39
Category Rank
#408 of 596
AI Consensus
84%
Trend
down
Per Platform
ChatGPT
35
Perplexity
39
Gemini
35

About

Luma Health is a San Francisco-based patient engagement and care orchestration platform that automates patient communication and administrative workflows for healthcare providers — providing appointment reminders, two-way SMS messaging, self-scheduling, waitlist management, referral coordination, and broadcast messaging that integrate directly with major electronic health record (EHR) systems including Epic, Cerner, Athenahealth, and eClinicalWorks. Backed by Andreessen Horowitz and other investors with $130+ million raised, Luma Health serves health systems, hospital groups, and ambulatory practices seeking to reduce no-shows and improve patient access.

Full profile
Pfizer logo

Pfizer

LeaderHealthcare Tech

Enterprise

Global biopharma with $63.6B FY2024 revenue; $43B Seagen ADC acquisition rebuilds post-COVID pipeline; patent cliff 2026-2028 for Eliquis; activist Starboard Value pushing restructuring.

AI VisibilityBeta
Overall Score
A93
Category Rank
#1 of 596
AI Consensus
80%
Trend
stable
Per Platform
ChatGPT
94
Perplexity
89
Gemini
94

About

Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The company trades on NYSE (PFE) and reported $63.6 billion in total revenues for FY2024, normalizing from pandemic highs of $100 billion-plus in 2021-2022 driven by Comirnaty COVID-19 vaccine revenues with BioNTech and Paxlovid COVID antiviral sales. CEO Albert Bourla has led a strategic pivot to reset the company's long-term growth profile, anchored by the landmark $43 billion acquisition of Seagen in December 2023, adding a world-class antibody-drug conjugate (ADC) oncology pipeline including Padcev, Tukysa, Adcetris, and Tivdak.

Full profile

AI Visibility Head-to-Head

39
Overall Score
93
#408
Category Rank
#1
84
AI Consensus
80
down
Trend
stable
35
ChatGPT
94
39
Perplexity
89
35
Gemini
94
39
Claude
92
41
Grok
98

Key Details

Category
Patient Engagement
Enterprise
Tier
Emerging
Leader
Entity Type
brand
company

Capabilities & Ecosystem

Capabilities

Only Luma Health
Patient Engagement

Integrations

Only Pfizer
Pfizer is classified as company.

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.